UPDATE ON EXON SKIPPING
Dear all,
Today Judith van Deutekom, Prosensa and LUMC Leiden, will
present on the World Muscle Society conference in Brugge the preliminary results
of the ongoing clinical trial in the Netherlands.
After intra muscular
injection of AON skipping exon 51 in the first patiënt, they were able to
demonstrate the presence of truncated Dystrophin in the biopsy which was taken
earlier this week, one month after injection. So far 3 patients are injected
without side effects.
Although more results will follow in the next month
we felt you all might like to know this first information.
Kind
regards,
Elizabeth
Vroom
Amsterdam, October
2006
UPPMD
and
Pat Furlong, President
Parent Project Muscular Dystrophy